Combination of an at1 angiotensin ii receptor antagonist and an immunosuppressant

摘要

The invention concerns the use of a pharmaceutical composition containing, in combination, an antagonist of AT1 angiotensin II receptors, in particular irbesartan, and an immunosuppressant, in particular cyclosporin A, for preventing or treating vascular complications after graft versus host reaction.